HopeStage
Back to all studies
CompletedNCT00528905

AZD3480 for cognitive difficulties in schizophrenia

About this titleRead the official source — NCT00528905
Medication studyAges 18–55United States + Canada
The study in practice

Understand this study

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.

Listed locations
Little Rock and 79 more locationsSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateAugust 2007
Recruitment status
Completed
Enrollment listed in the registry
400
Sponsor
AstraZeneca
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States, Canada
Age range
From 18 Years to 55 Years
Official registry ID
NCT00528905
Official title
Show the full official title

A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Little Rock, United States · Anaheim, United States · Cerritos, United States

77 more locations
  • Costa Mesa, United States
  • Escondido, United States
  • Garden Grove, United States
  • Long Beach, United States
  • Los Angeles, United States
  • Oceanside, United States
  • Pasadena, United States
  • Pico Rivera, United States
  • San Diego, United States
  • Santa Ana, United States
  • New Britain, United States
  • New Haven, United States
  • Washington D.C., United States
  • Boca Raton, United States
  • Coral Gables, United States
  • North Miami, United States
  • Orlando, United States
  • Tampa, United States
  • Atlanta, United States
  • Augusta, United States
  • Marietta, United States
  • Chicago, United States
  • Joliet, United States
  • Schaumburg, United States
  • Indianapolis, United States
  • New Orleans, United States
  • Glen Burnie, United States
  • Haverhill, United States
  • Pittsfield, United States
  • Minneapolis, United States
  • St Louis, United States
  • Las Vegas, United States
  • Nashua, United States
  • Cherry Hill, United States
  • Clementon, United States
  • East Orange, United States
  • Newark, United States
  • Paramus, United States
  • Brooklyn, United States
  • Cedarhurst, United States
  • Elmsford, United States
  • Glen Oaks, United States
  • Jamaica, United States
  • New York, United States
  • Rochester, United States
  • Staten Island, United States
  • Cincinnati, United States
  • Columbus, United States
  • Kettering, United States
  • Oklahoma City, United States
  • Allentown, United States
  • DuBois, United States
  • Norristown, United States
  • Philadelphia, United States
  • Charleston, United States
  • Memphis, United States
  • Austin, United States
  • DeSoto, United States
  • Houston, United States
  • Irving, United States
  • San Antonio, United States
  • Richmond, United States
  • Spokane, United States
  • Calgary, Canada
  • Red Deer, Canada
  • Penticton, Canada
  • Victoria, Canada
  • Winnipeg, Canada
  • Halifax, Canada
  • Sydney, Canada
  • Burlington, Canada
  • Greater Sudbury, Canada
  • Mississauga, Canada
  • Orléans, Canada
  • Toronto, Canada
  • Windsor, Canada
  • Montreal, Canada

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is AstraZeneca.

Did this study involve medication?

Yes. The study involved medication, including AZD3480.

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies